High-dose recombinant human erythropoietin for treatment of anemia in myelodysplastic syndromes and paroxysmal nocturnal hemoglobinuria: a pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/2226680

Download in:

View as

General Info

PMID
2226680